Related Experiment Video
Updated: Jan 11, 2026

04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.9K
Loco-regional Recurrence After Segmentectomy for Peripheral and Radiologically Solid-dominant Tumours
Takahiro Mimae1, Yoshihiro Miyata1, Norifumi Tsubokawa1
1Department of Surgical Oncology, Hiroshima University, Hiroshima 734-8551, Japan.
Summary
Segmentectomy offers similar local control to lobectomy for select early-stage non-small cell lung cancer. This study found comparable loco-regional recurrence rates between segmentectomy and lobectomy for these specific lung tumors.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonology
Background:
- Segmentectomy is a standard treatment for small, peripheral, solid-dominant non-small cell lung cancer (NSCLC).
- The comparative effectiveness of segmentectomy versus lobectomy for loco-regional control in these specific NSCLC cases remains unclear.
Purpose of the Study:
- To compare the loco-regional control effectiveness of segmentectomy and lobectomy.
- To evaluate recurrence patterns and prognosis in patients with specific NSCLC characteristics undergoing these surgical procedures.
Main Methods:
- Retrospective analysis of 941 patients with ≤2-cm, solid-dominant, peripheral NSCLC without clinical lymph node involvement.
- Patients underwent either segmentectomy (n=332) or lobectomy (n=609) between 2010 and 2020.
- Median follow-up was 48.8 months, with analysis of recurrence patterns and prognostic factors.
Main Results:
- Loco-regional recurrence occurred in 2% of segmentectomy patients versus 5% of lobectomy patients (P=.037).
- Among pure solid tumors, loco-regional recurrence was 4% for segmentectomy and 7% for lobectomy (P=.11).
- Multivariable analysis indicated that the surgical procedure was not a risk factor for loco-regional recurrence.
Conclusions:
- Segmentectomy provides comparable local control to lobectomy for selected small-sized, peripheral NSCLC.
- This finding holds true regardless of tumor malignant grade for these specific patient selections.

